Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ismail

Showing results (221-230 of 231) with videos related to

Pageof 24
Sort By:
JCO Oncology Practice|August 9, 2022
End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort StudyJesper van Breeschoten, Rawa K Ismail, Michel W J M Wouters, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2015
Colorectal Cancer Screening, Version 1.2015Dawn Provenzale, Kory Jasperson, Dennis J Ahnen, et al.
Melanoma Research|December 22, 2020
Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastasesRawa K Ismail, Nienke O Sikkes, Michel W J M Wouters, et al.
Melanoma Research|June 15, 2022
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitorsRawa K Ismail, Karijn P M Suijkerbuijk, Anthonius de Boer, et al.
Eclinicalmedicine|February 19, 2024
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021Olivier J van Not, Alfons J M van den Eertwegh, John B Haanen, et al.
International Journal of Cancer|June 20, 2020
Real-world outcomes of advanced melanoma patients not represented in phase III trialsMichiel C T van Zeijl, Rawa K Ismail, Liesbeth C de Wreede, et al.
Cancers|June 10, 2023
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint InhibitorsOlivier J van Not, Thijs T Wind, Rawa K Ismail, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2022
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort studyOlivier J van Not, Melissa M de Meza, Alfons J M van den Eertwegh, et al.
International Journal of Cancer|October 4, 2021
The unfavorable effects of COVID-19 on Dutch advanced melanoma careOlivier J van Not, Jesper van Breeschoten, Alfonsus J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2021
Adjuvant treatment for melanoma in clinical practice - Trial versus realityMelissa M de Meza, Rawa K Ismail, Daan Rauwerdink, et al.
Pageof 24

Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
JCO Oncology Practice|August 9, 2022
End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort StudyJesper van Breeschoten, Rawa K Ismail, Michel W J M Wouters, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2015
Colorectal Cancer Screening, Version 1.2015Dawn Provenzale, Kory Jasperson, Dennis J Ahnen, et al.
Melanoma Research|December 22, 2020
Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastasesRawa K Ismail, Nienke O Sikkes, Michel W J M Wouters, et al.
Melanoma Research|June 15, 2022
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitorsRawa K Ismail, Karijn P M Suijkerbuijk, Anthonius de Boer, et al.
Eclinicalmedicine|February 19, 2024
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021Olivier J van Not, Alfons J M van den Eertwegh, John B Haanen, et al.
International Journal of Cancer|June 20, 2020
Real-world outcomes of advanced melanoma patients not represented in phase III trialsMichiel C T van Zeijl, Rawa K Ismail, Liesbeth C de Wreede, et al.
Cancers|June 10, 2023
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint InhibitorsOlivier J van Not, Thijs T Wind, Rawa K Ismail, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2022
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort studyOlivier J van Not, Melissa M de Meza, Alfons J M van den Eertwegh, et al.
International Journal of Cancer|October 4, 2021
The unfavorable effects of COVID-19 on Dutch advanced melanoma careOlivier J van Not, Jesper van Breeschoten, Alfonsus J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2021
Adjuvant treatment for melanoma in clinical practice - Trial versus realityMelissa M de Meza, Rawa K Ismail, Daan Rauwerdink, et al.
Pageof 24